文献速递慢性肾脏病肾小球疾病

1型糖尿病中与糖尿病肾病相关的尿液细胞外囊泡microRNA全基因组分析

Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.
PubMed 文献 · Kidney Int Rep · 2017-12-01

本研究基于匹兹堡大学糖尿病并发症流行病学研究,对1型糖尿病患者不同肾病分级和微量白蛋白尿状态的尿液细胞外囊泡进行小RNA测序,鉴定出一组与糖尿病肾病发生及微量白蛋白尿状态相关的miRNA,这些miRNA靶向肾纤维化相关通路,可能作为无创生物标志物。

要点

  • 尿液细胞外囊泡中富集特定miRNA,其浓度变化与糖尿病肾病发生相关。
  • 部分miRNA与微量白蛋白尿状态及糖化血红蛋白水平相关。
  • 这些miRNA直接靶向肾纤维化相关通路,如TGF-β和PTEN。

核心结论

  • 与糖尿病肾病发生或微量白蛋白尿状态相关的多个miRNA直接靶向肾纤维化相关通路,是糖尿病肾病和微量白蛋白尿的潜在生物标志物。

研究设计与样本

  • 基于匹兹堡大学糖尿病并发症流行病学研究,收集1型糖尿病患者十年间预设间隔的尿液,按肾病或微量白蛋白尿分级(正常、显性、间歇性、持续性)分组,分离细胞外囊泡并进行小RNA二代测序。

主要发现

  • 与耗竭细胞外囊泡的样本相比,尿液细胞外囊泡中富集一组miRNA。
  • 鉴定出多个miRNA的浓度变化与糖尿病肾病发生、微量白蛋白尿状态及糖化血红蛋白水平等变量相关。

临床怎么用

  • 这些miRNA可能作为糖尿病肾病和微量白蛋白尿的无创生物标志物,用于早期检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Diabetic nephropathy (DN) is a form of progressive kidney disease that often leads to end-stage renal disease (ESRD). It is initiated by microvascular complications due to diabetes. Although microalbuminuria (MA) is the earliest clinical indication of DN among patients with type 1 diabetes (T1D), it lacks the sensitivity and specificity to detect the early onset of DN. Recently, microRNAs (miRNAs) have emerged as critical regulators in diabetes as well as various forms of kidney disease, including renal fibrosis, acute kidney injury, and progressive kidney disease. Additionally, circulating extracellular miRNAs, especially miRNAs packaged in extracellular vesicles (EVs), have garnered significant attention as potential noninvasive biomarkers for various diseases and health conditions. METHODS: As part of the University of Pittsburgh Epidemiology of Diabetes Complications (EDC) study, urine was collected from individuals with T1D with various grades of DN or MA (normal, overt, intermittent, and persistent) over a decade at prespecified intervals. We isolated EVs from urine and analyzed the small-RNA using NextGen sequencing. RESULTS: We identified a set of miRNAs that are enriched in urinary EVs compared with EV-depleted samples, and identified a number of miRNAs showing concentration changes associated with DN occurrence, MA status, and other variables, such as hemoglobin A1c levels. CONCLUSION: Many of the miRNAs associated with DN occurrence or MA status directly target pathways associated with renal fibrosis (including transforming growth factor-β and phosphatase and tensin homolog), which is one of the major contributors to the pathology of DN. These miRNAs are potential biomarkers for DN and MA.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ghai V, Wu X, Bheda-Malge A, et al. Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes. Kidney Int Rep. 2017. PMID: 29854963. doi:10.1016/j.ekir.2017.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。